Hillcrest Energy Technologies Ltd (CSE:HEAT, OTCQB:HLRTF) told investors that 2023 marks a transitional year in its story, with the focus shifting to the application of its core ZVS inverter technology into new products and end uses.
Providing an update on Hillcrest’s anticipated development and commercialization targets for 2023, the company said it starts 2023 in a strong position established by last month's completion of its first commercial prototype, an 800-volt, 250-kilowatt traction inverter for the EV market.
ACME Lithium Inc. (CSE:ACME, OTCQB:ACLHF) said it has now kicked off drilling at its Shatford Lake project in southeastern Manitoba, Canada, having earlier unveiled plans for a program of up to 5,000 meters (m).
Drill targets from multiple sites have been identified and include numerous pegmatites, some of which were undocumented prior to last year's summer exploration, said ACME.
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) told investors that Dr Peter Dicpinigaitis, regarded as an authority on clinical studies of coughs, will be the medical consultant on its Phase 2b clinical study of NP-120 (Ifenprodil).
As recently reported, Algernon is planning a 180-patient, 90-day, clinical trial set to begin in the third quarter of this year.
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) will hold a webinar on Thursday, January 19, 2023, at 2:00 PM ET, where CEO Ilan Sobel will present the Q4 2022 VINIA sales results, provide an update on Cannabis commercialization, and will also "unpack" the 2023 growth priorities which will deliver the 2023 company revenue guidance of US$17M - $20 million. "We are entering our second full year of VINIA commercialization, and it is remarkable how our organization has so quickly transformed into this commercial machine. I look forward to sharing new details on our 2023 priorities, and to reiterate my confidence in this being a historical pivot year for BioHarvest Sciences", states CEO Ilan Sobel, adding "We are targeting a second consecutive year of 3x revenue growth, and to become overall cash flow positive in Q4. These are aggressive goals, but our team is mobilized to execute on a 2023 plan designed to capitalize on current market opportunities across both our polyphenol and cannabis verticals." Register for free at: https://us02web.zoom.us/webinar/register/WN_yhEEoY6FQie83d_YCOrMPA.
Rio2 Limited (TSX-V:RIO, OTCQX:RIOFF) announced that today it granted 7.5 million incentive stock options to purchase Rio2 common shares to directors, officers, employees and consultants pursuant to the Rio2’s stock option plan. The options have an expiry date of January 11, 2028, and will vest one-third thereof on each of the first, second and third anniversaries of grant. Each stock option entitles the holder to purchase one Rio2 common share at a price of C$0.30 for a period of five years from the date of grant.
Westwater Resources Inc (NYSE-A:WWR) said its chief financial officer Steve Cates will be participating in a Fireside Chat with Water Tower Research on Thursday, January 19, 2023, at 2pm Eastern Time. Cates will discuss the changing dynamic in the graphite market, the growing focus of battery manufacturers on securing a domestic supply of critical metals, as well as other company updates, Westwater said. Those interested in joining the fireside chat can register here: https://us06web.zoom.us/webinar/register/WN_NSVZrOkIRva_ra4yWXvVQg.